These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9270410)

  • 1. Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors.
    Mykkänen L; Haffner SM; Rönnemaa T; Bergman RN; Laakso M
    Am J Epidemiol; 1997 Aug; 146(4):315-21. PubMed ID: 9270410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.
    Meigs JB; D'Agostino RB; Wilson PW; Cupples LA; Nathan DM; Singer DE
    Diabetes; 1997 Oct; 46(10):1594-600. PubMed ID: 9313755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinsulinemia and clustering of cardiovascular risk factors in middle-aged hypertensive Finnish men and women.
    Vanhala MJ; Kumpusalo EA; Pitkäjärvi TK; Notkola IL; Takala JK
    J Hypertens; 1997 May; 15(5):475-81. PubMed ID: 9169999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic characteristics of glucose intolerance: the critical role of obesity.
    Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
    Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
    Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study.
    Meigs JB; Nathan DM; Wilson PW; Cupples LA; Singer DE
    Ann Intern Med; 1998 Apr; 128(7):524-33. PubMed ID: 9518396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors?
    Lind L; Lithell H; Pollare T
    J Hypertens Suppl; 1993 Jun; 11(4):S11-6. PubMed ID: 8377030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose.
    Hong J; Gui MH; Gu WQ; Zhang YF; Xu M; Chi ZN; Zhang Y; Li XY; Wang WQ; Ning G
    Diabet Med; 2008 Jan; 25(1):73-9. PubMed ID: 18199133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome.
    Haffner SM; Mykkänen L; Valdez RA; Stern MP; Holloway DL; Monterrosa A; Bowsher RR
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1806-10. PubMed ID: 7989488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of the degrees of insulin resistance and first-phase insulin secretion of beta-cells in metabolic syndrome patients with different glucose tolerance].
    Hong J; Gu WQ; Zhang YF; Guo Y; Chen HM; Zhang LZ; Zhao YJ; Ning G
    Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1952-6. PubMed ID: 14703429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
    Shalitin S; Abrahami M; Lilos P; Phillip M
    Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of traits of metabolic syndrome on β-cell function and insulin resistance in normal fasting, normal glucose tolerant subjects.
    Cubeddu LX; Hoffmann IS
    Metab Syndr Relat Disord; 2012 Oct; 10(5):344-50. PubMed ID: 22803772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests.
    Hong J; Zhang YF; Gu WQ; Zhang YW; Su YX; Chi ZN; Wang WQ; Li XY; Ning G
    Endocrine; 2008; 34(1-3):75-80. PubMed ID: 18979203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
    Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
    Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals.
    Haffner SM; Ferrannini E; Hazuda HP; Stern MP
    Hypertension; 1992 Jul; 20(1):38-45. PubMed ID: 1618551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.